首頁 > 市場調查報告書 > 消費品

市場調查報告書

商品編碼

1638825

2024 - 2032 年小瓶市場機會、成長動力、產業趨勢分析與預測

Vials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年11月05日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球小瓶市場達到 122 億美元，預計 2024 年至 2032 年複合年成長率為 9.1%。。這些容器在維持藥物的無菌性和穩定性方面發揮著至關重要的作用，特別是在醫療保健環境中。小瓶通常用於包裝疫苗、注射和生物製劑，有單劑量和多劑量兩種形式。它們用橡膠塞或蓋子密封，以防止在給藥前污染。

該市場的成長主要是由藥品需求不斷成長推動的，特別是注射藥物和生物製劑，它們需要高品質的小瓶來保持藥物的穩定性和安全性。慢性病的增加以及對全球疫苗接種運動的日益重視，大大增加了用於儲存和分發疫苗的小瓶的使用。此外，小瓶模型的持續技術發展，例如改進的玻璃配方和防篡改類型，增強了它們的吸引力並有助於市場成長。

市場依準備度分為即用型（RTU）和即用型（RTS）小瓶。 RTU 細分市場目前佔據市場主導地位，預計在預測期內複合年成長率為 9.4%。 RTU 小瓶配有預先計量的藥物劑量，減少了進一步準備的需要，並最大限度地降低了污染風險。此功能在效率和精度至關重要的臨床環境中特別有用。 RTU 西林瓶無需滅菌和填充，從而簡化了藥品製造流程，從而降低了勞動力和營運成本，同時最佳化了生產效率。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	122 億美元
預測值	265 億美元
複合年成長率	9.1%

從應用來看，市場分為小分子、生物製劑和診斷。由於擴大使用生物療法來治療自體免疫疾病等慢性病，生物製劑領域在 2023 年佔據最大佔有率，達到 48.6%。由於生物製劑源自生物體，因此需要專門的包裝來保持其穩定性和功效，這使得小瓶成為其分銷的重要組成部分。生物相似藥的可用性不斷增加，為患者提供了更多的治療選擇，進一步支持了該細分市場的成長。

美國在北美小瓶市場中佔據主導地位，預計到2023 年將繼續引領市場，複合年成長率預計為8.8%。解決方案產生了很高的需求。對藥物開發的大量投資，特別是在生物製品和個人化醫療方面，強調需要滿足嚴格監管標準的專用藥瓶，同時確保藥物的穩定性和安全性。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病和老年人口增加
  - 生物製劑和生物相似藥的興起
  - 玻璃技術的進步
  - 將製造外包給 CDMO 的趨勢增加
- 產業陷阱與挑戰
  - 嚴格的監管要求
  - 獲得替代藥物輸送方法
成長潛力分析
監管環境
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按準備情況，2021 - 2032 年

主要趨勢
即用型 (RTU)
準備滅菌 (RTS)

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
小分子
生物製劑
診斷

第 7 章：市場估計與預測：按材料分類，2021 - 2032 年

主要趨勢
玻璃
聚合物
混合

第 8 章：市場估計與預測：按規模，2021 - 2032

主要趨勢
<1毫升
1毫升 - 2毫升
3毫升 - 5毫升
6 毫升 - 10 毫升
10 - 20 毫升
20 - 30 毫升
>30 毫升

第 9 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院和診所
製藥和生物技術公司
合約開發與製造組織 (CDMO)
診斷實驗室
其他最終用戶

第 10 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 11 章：公司簡介

Amcor
Arab Pharmaceutical Glass
Corning
Daikyo Seiko
DWK Life Sciences
Gerresheimer AG
KISHORE GROUP
Mitsubishi Gas Chemical Company
Nipro
Pacific Vial Manufacturing
SCHOTT Pharma (SCHOTT Group)
SGD Pharma
Shandong Province Medicinal Glass
SHIOTANI GLASS
Stevanato Group
West Pharmaceutical Services
Wuxi NEST Biotechnology

簡介目錄

Product Code: 12130

The Global Vials Market reached USD 12.2 billion in 2023 and is projected to expand at a CAGR of 9.1% from 2024 to 2032. Vials are small, sealed containers made from glass or plastic, primarily used for storing liquids, powders, or freeze-dried medications. These containers play a crucial role in maintaining the sterility and stability of drugs, particularly in healthcare environments. Vials are commonly used to package vaccines, injectables, and biologics, and they come in both single-use and multi-dose formats. They are sealed with rubber stoppers or caps to prevent contamination before the medication is administered.

The market's growth is largely driven by the increasing demand for pharmaceuticals, particularly injectable drugs and biologics, which require high-quality vials to maintain drug stability and safety. The rise in chronic diseases and the growing emphasis on global vaccination campaigns have significantly boosted the use of vials for storing and distributing vaccines. Additionally, ongoing technological developments in vial models, such as improved glass formulations and tamper-proof type, enhance their appeal and contribute to market growth.

The market is categorized based on preparation into ready-to-use (RTU) and ready-to-sterilize (RTS) vials. The RTU segment currently dominates the market and is expected to grow at a CAGR of 9.4% during the forecast period. RTU vials come with pre-measured doses of medication, reducing the need for further preparation and minimizing the risk of contamination. This feature is particularly beneficial in clinical settings, where efficiency and precision are critical. RTU vials streamline pharmaceutical manufacturing processes by eliminating the need for sterilization and filling, thus reducing labor and operational costs while optimizing production efficiency.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$12.2 Billion
Forecast Value	$26.5 Billion
CAGR	9.1%

In terms of application, the market is divided into small molecules, biologics, and diagnostics. The biologics segment held the largest share of 48.6% in 2023, driven by the increasing use of biologic therapies to treat chronic conditions, such as autoimmune diseases. As biologics are derived from living organisms, they require specialized packaging to preserve their stability and efficacy, making vials an essential component of their distribution. This segment's growth is further supported by the increasing availability of biosimilars, providing more treatment options for patients.

The U.S. dominates the North American vials market and is expected to continue leading the market with a projected CAGR of 8.8% in 2023. This dominance can be attributed to the country's strong pharmaceutical and biotechnology sectors, which create a high demand for advanced packaging solutions. Significant investments in drug development, particularly in biologics and personalized medicine, emphasize the need for specialized vials that meet stringent regulatory standards while ensuring drug stability and safety.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising chronic diseases and geriatric population
  - 3.2.1.2 Rise in biologics and biosimilars
  - 3.2.1.3 Advancements in glass technology
  - 3.2.1.4 Increased trend of outsourcing manufacturing to CDMOs
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory requirements
  - 3.2.2.2 Access to alternative drug delivery methods
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Preparation, 2021 - 2032 ($ Mn and Units)

5.1 Key trends
5.2 Ready To Use (RTU)
5.3 Ready To Sterilize (RTS)

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Units)

6.1 Key trends
6.2 Small molecules
6.3 Biologics
6.4 Diagnostics

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn and Units)

7.1 Key trends
7.2 Glass
7.3 Polymer
7.4 Hybrid

Chapter 8 Market Estimates and Forecast, By Size, 2021 - 2032 ($ Mn and Units)

8.1 Key trends
8.2 <1 ml
8.3 1 ml - 2 ml
8.4 3 ml - 5 ml
8.5 6 ml - 10 ml
8.6 10 - 20 ml
8.7 20 - 30 ml
8.8 >30 ml

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)

9.1 Key trends
9.2 Hospitals & clinics
9.3 Pharma & biotech companies
9.4 Contract Development And Manufacturing Organizations (CDMOs)
9.5 Diagnostic laboratories
9.6 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Italy
- 10.3.5 Spain
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE